The ODM-1000A/P intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT), and corneal thickness (CT).

The ODM-1000A intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT).

The ODM-1000P intended used for ophthalmology to accurately measure the corneal thickness (CT).

Ultrasound Imaging of the Eye Axial biometric parameter measurement of the Eye

Device Description

ODM-1000 A/P Biometer is an ultrasonic measuring instrument of pulse reflection. It contains two independent units: A-Mode Axis Biometric Parameter Measuring Unit and P-Mode Corneal Thickness Measuring Unit. It can be selected by user to configure:

ODM-1000A Ultrasonic A-Biometer (only for axial A biometry)

ODM-1000P Pachymeter (only for corneal thickness measurement)

The A-Biometer consists of a 10MHz A-probe and biometric unit. The axial biometry is the measurement for anterior chamber depth (ACD), lens thickness (LENS), vitreous length (VITR) and axial length (AL).

Corneal thickness Pachymeter consists of a 20MHz-pachymetric probe and the measuring unit. It is on the basis of the measurement of time interval between the anterior and post interface reflection wave to get the thickness of the cornea.

The ODM-1000A/P includes A-mode axial biometric parameter measurement and P-mode Corneal thickness measurement. Users can switch between these two modes through keyboard.

In A-mode, the 10MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by anterior chamber, lens and vitreum. Each length and their sum (AL) are calculated by measuring the time spent in different parts.

In P-mode, the 20MHz transducer transmits ultrasound into eye tissue and receives its echo reflected back by the anterior and post interface reflection pulse of the cornea, and then measure the time interval between two reflection pulse to get the thickness of the cornea.

AI/ML Overview

The provided 510(k) summary for the ODM-1000A/P Ultrasonic Biometer/Pachymeter for Ophthalmology does not contain specific acceptance criteria or a detailed clinical study demonstrating that the device meets such criteria.

Instead, it states that the device is "equivalent in safety and efficacy to the legally marketed predicate device" based on non-clinical tests and the assertion that a clinical test is "Not required."

Therefore, I cannot provide the requested information in the format specified, as the necessary details are absent from the document.

However, I can extract the information that is present regarding performance and predicate devices:

1. A table of acceptance criteria and the reported device performance:

This information is not provided in the document. The submission relies on establishing substantial equivalence to a predicate device rather than presenting specific quantitative acceptance criteria and then showing the device meets them through testing.

2. Sample size used for the test set and the data provenance:

Sample Size: Not applicable, as no clinical test set is described.
Data Provenance: Not applicable, as no clinical test set is described.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

Not applicable, as no clinical test set requiring expert ground truth establishment is described.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

Not applicable, as no clinical test set requiring adjudication is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

Not applicable. This device is an ultrasonic biometer/pachymeter, not an AI-assisted diagnostic tool for image interpretation by human readers. Therefore, an MRMC study related to AI assistance is not relevant to this specific device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

The device itself is a measurement tool. Its "standalone performance" is implied by its design and the non-clinical tests performed. It doesn't have an "algorithm only" component in the sense of AI for image interpretation separate from a human, but rather directly measures biological parameters. The submission states "Not required" for clinical tests, implying that standalone performance was deemed sufficient by comparison to the predicate.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

Not applicable, as no clinical study or ground truth establishment process is detailed in the document. The "ground truth" for the device's function would inherently be the physical dimensions it is designed to measure (axial length, anterior chamber depth, lens thickness, corneal thickness), but how this "ground truth" was established for testing purposes is not described.

8. The sample size for the training set:

Not applicable. This device is an ultrasonic measurement instrument, not a machine learning or AI algorithm that requires a separate training set.

9. How the ground truth for the training set was established:

Not applicable, as no training set is described for this type of device.

Summary of available information related to performance:

The document states that the ODM-1000A/P device's performance relies on its technological characteristics and non-clinical tests for safety and electromagnetic compatibility (EMC).

Non-clinical tests performed:
- Safety Test (IEC 60601-1, Tested by TÜV)
- EMC Test Report (IEC 60601-1-2, Tested by TÜV)
- Acoustic output Test (FDA Guidance Document)
- Biological Safety Test (ISO 10993, Tested by TÜV)

The conclusion drawn from these tests, and the assertion that clinical tests are not required, is that the device is "equivalent in safety and efficacy to the legally marketed predicate device" (Micro Medical Devices' PalmScan AP2000/A2000/P2000 Devices, K043287). This strategy is typical for a 510(k) submission seeking substantial equivalence rather than demonstrating de novo performance against specific clinical acceptance criteria.

Summary

{0}------------------------------------------------

510(k) Premarket Notification Model ODM-1000A/P Ultrasonic Biometer/Pachymeter For Ophthalmology

Attachment 8

JAN 3 1 2007

7 K063472

510(k) SUMMARY

1) Submitter Information

Name: MEDA. Co., Ltd. Address: Room D, F3, Building C2, Xinmao Science Skill Park, Huayuan Industry Development Area, Tianjin, China

Phone: 86-22-83713808 Fax: 86-22-83713880

Contact person: Edward A. Kroll Spectre Solutions, Inc. 5905 Fawn Lane Cleveland, Ohio 44141 Phone: (440) 546-9810 Fax: (440) 546-9124

Data Prepared: September 16, 2006

2) Name of Device

Trade Name:

ODM-1000A/P Biometer ODM-1000A Ultrasonic A-Biometer ODM-1000P Ultrasonic Pachymeter

Common Name:

Ultrasound A/P Scan System for Ophthalmology Ultrasound A Scan for Ophthalmology Ultrasound Pachymeter ·

Classification Name: Ultrasonic Pulsed Echo Imaging System Regulation Number: 892.1560 Product Code: 90-IYO

{1}------------------------------------------------

3) Predicate Devices

Micro Medical Devices' PalmScan AP2000/A2000/P2000 Devices, K043287

4) Intended Use

The ODM-1000A/P intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT), and corneal thickness (CT).

The ODM-1000A intended used for ophthalmology to accurately measure the axial length (AL), anterior chamber depth (ACD), lens thickness (LT).

The ODM-1000P intended used for ophthalmology to accurately measure the corneal thickness (CT).

5) Device Description

ODM-1000A Ultrasonic A-Biometer (only for axial A biometry)

ODM-1000P Pachymeter (only for corneal thickness measurement)

6) Technological characteristics

a) Devices Description

The ODM-1000A/P includes A-mode axial biometric parameter measurement and P-mode Corneal thickness measurement. Users can switch between these two modes through keyboard.

{2}------------------------------------------------

b) Performance Data

Non-clinical test

Compliance Tests for ODM-1000A/P are as follows: Safety Test (IEC 60601-1, Tested by TÜV) EMC Test Report (IEC 60601-1-2, Tested by TÜV) Acoustic output Test (FDA Guidance Document "Information for Manufacture Seeking Marketing Clearance of Diagnostic Ultrasound System and Transducers" ) Biological Safety Test (ISO 10993, Tested by TÜV)

Clinical test

Not required

Conclusions

The ODM-1000A/P Ultrasonic Biometer/Pachymeter for Ophthalmology and The ODM-1000A Ultrasonic Biometer for Ophthalmology, The ODM-1000P Ultrasonic Pachymeter

Are equivalent in safety and efficacy to the legally marketed predicate device.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle with its wings spread, with three wavy lines below the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Edward A. Kroll President Meda, Ltd. 5905 Fawn Lane CLEVELAND OH 44141

JAN 3 1 2007

Re: K063472

Trade Name: Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: IYO and ITN Dated: November 11, 2006 Received: December 5, 2006

Dear Mr. Kroll:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology, as described in your premarket notification:

Transducer Model Number

A-Scan (10MHz) A-Scan (20MHz)

Image /page/3/Picture/13 description: The image is a circular logo or emblem. The text "1906-2006" is at the top of the circle. The letters "FDA" are in the center of the circle in a bold font. The word "Centennial" is below the letters "FDA". There are three stars below the word "Centennial".

Protecting and Promoting Public Health

{4}------------------------------------------------

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.

The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

{5}------------------------------------------------

If you have any questions regarding the content of this letter, please contact Andrew Kang, M.D.

(240) 276, 2666 at (240) 276-3666.

Sincerely yours,

Nancy Brogdon
Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure(s)

{6}------------------------------------------------

Indications for Use

510(k) Number (if known): 780

Device Name: Meda Model ODM 1000 A/P Ultrasonic Biometer for Ophthalmology

Indications for Use:

Ultrasound Imaging of the Eye Axial biometric parameter measurement of the Eye

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page of

(Posted November 13, 2003)

Nancy C. Brogdon

(Division Sign Off) Division of Reproductive, Abdomina and Radiological Devices 510(k) Number _

{7}------------------------------------------------

MEDA.CO., LTD.

Attachment 1

DIAGNOSTIC ULTRASOUND INDICATIONS FOR USE FORM

ODM-1000A/P & ODM-1000A, System: Transducer: __________________________________________________________________________________________________________________________________________________________________ A-Scan (10MHz)

Intended Use: Diagnostic ultrasound imaging K063472

Clinical Application	Mode Of Operation
	A	B	M	PWD	CWD	Color Doppler	Amplitude Doppler	Color Velocity Imaging	Combined (specify)	Other* (Specify)
Ophthalmic	N
Fetal
Abdominal
Intraoperative (Specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neuonatal Cephalic
Adult Cephalic
Cardicac
Transesophageal
transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Other (Specify)

N= new indication; P= previously cleared by FDA; E= added under Appendix E

Additional Contents

Additional Contents: _________________________________________________________________________________________________________________________________________________________

(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation

Prescription Use (Per 21 CFR 801.109)

Vareus Broadon

(Division Sign Division of Reproductive, Pagearld Radiological Device 510(k) Number

{8}------------------------------------------------

DIAGNOSTIC ULTRASOUND INDICATIONS FOR USE FORM

ODM-1000A/P & ODM-1000P, System: Transducer: __________________________________________________________________________________________________________________________________________________________________

Intended Use: Diagnostic ultrasound imaging

Ko6347a

Clinical Application	Mode Of Operation
	A	B	M	PWD	CWD	ColorDoppler	AmplitudeDoppler	ColorVelocityImaging	Combined(specify)	Other*(Specify)
Ophthalmic	N
Fetal
Abdominal
Intraoperative (Specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neuonatal Cephalic
Adult Cephalic
Cardicac
Transesophageal
transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletaiConventional
Musculo-skeletal Superficial
Other (Specify)

N= new indication; P= previously cleared by FDA; E= added under Appendix E

Additional Contents:

Pachymetric probe

(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of Center for Devices and Radiological Health, Office of Device Evaluation

Prescription Use (Per 21 CFR 801.109)

Nancy C. Hogdon

(Division Sigr dominal. Division of Reproductive, Al and Sedinlogical Devices 510(k) Number __

Page 2

Regulation Number and Section

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.